Authors:
GRIESINGER F
ELFERS H
LUDWIG WD
FALK M
RIEDER H
HARBOTT J
LAMPERT F
HEINZE B
BUCHNER T
HOELZER D
THIEL E
WORMANN B
FONATSCH C
HIDDEMANN W
Citation: F. Griesinger et al., 6 DIFFERENT HRX-FEL FUSION TRANSCRIPTS IN PRE-PRE-B-ALL WITH AND WITHOUT CYTOGENETIC DEMONSTRATION OF T(4-11), Blood, 82(10), 1993, pp. 10000036-10000036
Authors:
HIDDEMANN W
REUTER C
SCHLEYER E
UNTERHALT M
WORMANN B
BUCHNER T
Citation: W. Hiddemann et al., CORRELATION OF BLAST CELL PROLIFERATIVE ACTIVITY AND IN-VITRO RESPONSE TO GM-CSF WITH THE ANTILEUKEMIC ACTIVITY OF TAD-9 INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA, Blood, 82(10), 1993, pp. 10000125-10000125
Citation: Rp. Gale et al., CHEMOTHERAPY VERSUS BONE-MARROW TRANSPLANTS FOR ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION, Blood, 82(10), 1993, pp. 10000168-10000168
Authors:
HOELZER D
ARNOLD R
AYDEMIR U
BUCHNER T
FREUND M
GASSMANN W
GOKBUGET N
HIDDEMANN W
KOCH P
LOFFLER H
LUDWIG WD
MASCHMEYER G
THIEL E
VOLKERS B
Citation: D. Hoelzer et al., RESULTS OF INTENSIFIED CONSOLIDATION THERAPY IN 4 CONSECUTIVE GERMAN MULTICENTER STUDIES FOR ADULT ALL, Blood, 82(10), 1993, pp. 10000193-10000193
Authors:
SCHLEYER E
BIRKFELLNER T
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: E. Schleyer et al., INTERMITTENT SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (IS-HAM) FOR REFRACTORY ACUTE LEUKEMIAS - A PHARMACOLOGICALLY DESIGNED PHASE-II STUDY, Blood, 82(10), 1993, pp. 10000256-10000256
Authors:
FRASSONI F
LABOPIN M
PALUTMZALI P
BUCHNER T
BURNETT A
CLINK HM
GLUCKMAN E
GOLDSTONE A
GRATWOHL A
HAGENBEEK A
HERVE P
LOWENBERG B
HOELTZER D
MANDELLI F
PRENTICE HG
RINGDEN O
RIZZOLI V
SCHATTEMBERG A
SIERRA J
TURA S
GORIN NC
Citation: F. Frassoni et al., EVOLUTION OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN EUROPE - IMPROVED RESULTS FOR PATIENTS WITH ACUTE-LEUKEMIA IN 1ST REMISSION, Blood, 82(10), 1993, pp. 10000291-10000291
Authors:
FRASSONI F
LABOPIN M
PALUTMZALI P
BUCHNER T
BURNETT A
CLINK HM
GLUCKMAN E
GOLDSTONE A
GRATWOHL A
HAGENBEEK A
HERVE P
LOWENBERG B
HOELTZER D
MANDELLI F
PRENTICE HG
RINGDEN O
RIZZOLI V
SCHATTEMBERG A
SIERRA J
TURA S
GORIN NC
Citation: F. Frassoni et al., RISK OF EVENTS BEYOND 2-YEARS FROM BONE-MARROW TRANSPLANT FOR ACUTE-LEUKEMIA IN EUROPE, Blood, 82(10), 1993, pp. 10000345-10000345
Authors:
RUSTEMEYER P
KONEMANN S
ZUHLSDORF M
WARTHORST U
HIDDEMANN W
BUCHNER T
WORMANN B
Citation: P. Rustemeyer et al., HETEROGENOUS GROWTH-POTENTIAL OF AML COLONY-FORMING CELLS IN SUBPOPULATIONS DEFINED BY CD34 AND CD38, Blood, 82(10), 1993, pp. 10000490-10000490
Authors:
ZUHLSDORF M
WEISSPFENNIG S
AMELING C
BUSEMANN C
HIDDEMANN W
BUCHNER T
Citation: M. Zuhlsdorf et al., FREQUENCY-DISTRIBUTIONS OF ARA-C SENSITIVITY FOR AML COLONY-FORMING CELLS AND NORMAL PROGENITORS SHIFTED BY PRIMING WITH RHGM-CSF AND RH IL-3, Blood, 82(10), 1993, pp. 10000507-10000507
Authors:
GRIESINGER F
JANESZEK H
BREUKELMANN D
ENGLERT M
HUMPE A
BUCHNER T
HIDDEMANN W
WORMANN B
Citation: F. Griesinger et al., HIGH-INCIDENCE OF RAG-1 AND RAG-2 TRANSCRIPTS IN ALL AND ANLL - CORRELATION TO CROSS-LINEAGE TCR AND IGH REARRANGEMENTS, Blood, 82(10), 1993, pp. 10000525-10000525